skip to: main content | section menu | full site menu

Technology Transfer from the University of Oxford

Isis News Edition 29 - Winter 1999

Monoclonal Antibodies
A Major Role for Monoclonal Antibodies in the Successful Translation of Progress in Immunobiology into New Therapeutics
- Oxford Innovation Society Lecture - September 1999 Dr Christopher Mirabelli, LeukoSite Inc.

Reprogramming the Immune System
Oxford Innovation Society Lecture - September 1999 Professor Herman Waldmann, Sir William Dunn School of Pathology

Oxford Gene Technology
Oxford Gene Technology appoints Dr Andew Millar as CEO of Its New Operations Subsidiary

Isis College Fund
Following approaches from several individual colleges Isis proposed and supported the establishment of a multimillion-pound fund to provide second and third round finance for Oxford spin-out companies.

Oxagen Ltd
Work emanating from Professor Bill Cookson's Asthma Genetics Group, supported principally by the Wellcome Trust and the National Asthma Campaign, and based at the Wellcome Trust Centre for Human Genetics, has resulted in a portfolio of patents in the areas of asthma and atopy. The intellectual property includes linkages, associations and single nucleotide polymorphisms.